NCT00318643View on ClinicalTrials.gov

Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

March 30, 2006

Primary Completion Date

August 11, 2009

Study Completion Date

August 11, 2009

Conditions
Bladder Cancer
Interventions
DRUG

Mitomycin C

intravesical administration

DRUG

Chemophase

intravesical administration

Trial Locations (5)

32608

Malcolm Randall Veterans Administration Urology Section (112-C), Gainesville

33612

James A. Haley Veterans Hospital, Tampa

34652

Advanced Research Institute, New Port Richey

85032

BCG Oncology, Phoenix

91942

MedResearch, La Mesa

Sponsors
All Listed Sponsors
lead

Halozyme Therapeutics

INDUSTRY